Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic beta-cell protection. Yi X, Zimath PL, Martin-Vazquez E, Oliveira JG, et al. J Autoimmun 2025;156:103469.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yi X, Zimath PL, Martin-Vazquez E, Oliveira JG, et al. Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic beta-cell protection. J Autoimmun 2025;156:103469.
PMID: 40782630